Technical Analysis for LIVN - LivaNova PLC

Grade Last Price % Change Price Change
D 50.76 0.32% 0.16
LIVN closed up 0.32 percent on Monday, March 18, 2024, on approximately normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
Bullish Engulfing Bullish 0.00%
Hammer Candlestick Bullish 0.00%
Multiple of Ten Bullish Other 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Doji - Bullish? Reversal 0.32%
Gapped Down Weakness 0.32%
Oversold Stochastic Weakness 0.32%
Fell Below 200 DMA Bearish -0.70%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 12 hours ago
60 Minute Opening Range Breakdown about 14 hours ago
Fell Below Lower Bollinger Band about 14 hours ago
Fell Below Previous Day's Low about 14 hours ago
Down 1% about 14 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

LivaNova PLC Description

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Surgery Medical Equipment Healthcare Providers Heart Failure Cardiology Depression Prosthetics Obstructive Sleep Apnea Repair Products Cardiac Surgery Cardiopulmonary Bypass Therapeutic Solutions

Is LIVN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 59.84
52 Week Low 41.445
Average Volume 574,330
200-Day Moving Average 51.28
50-Day Moving Average 51.60
20-Day Moving Average 53.91
10-Day Moving Average 52.27
Average True Range 1.70
RSI (14) 42.53
ADX 19.1
+DI 16.08
-DI 27.36
Chandelier Exit (Long, 3 ATRs) 52.71
Chandelier Exit (Short, 3 ATRs) 53.93
Upper Bollinger Bands 57.95
Lower Bollinger Band 49.88
Percent B (%b) 0.11
BandWidth 14.97
MACD Line -0.13
MACD Signal Line 0.45
MACD Histogram -0.5802
Fundamentals Value
Market Cap 2.73 Billion
Num Shares 53.9 Million
EPS 0.05
Price-to-Earnings (P/E) Ratio 1015.20
Price-to-Sales 2.45
Price-to-Book 2.22
PEG Ratio 40.05
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 52.48
Resistance 3 (R3) 52.31 51.58 52.19
Resistance 2 (R2) 51.58 51.14 51.66 52.10
Resistance 1 (R1) 51.17 50.87 51.37 51.33 52.00
Pivot Point 50.43 50.43 50.53 50.51 50.43
Support 1 (S1) 50.02 49.99 50.23 50.19 49.52
Support 2 (S2) 49.29 49.72 49.37 49.42
Support 3 (S3) 48.88 49.29 49.33
Support 4 (S4) 49.04